Results 31 to 40 of about 2,172,183 (156)

Acute generalized exanthematous pustulosis due to dextromethorphan [PDF]

, 2013
Acute generalized exanthematous pustulosis (AGEP) is a rare, severe, pustular, cutaneous reaction. We report a case in which a patient developed AGEP after the intake of 3 different antitussive agents containing dextromethorphan as the only ingredient in
Perez Paredes, G., Rodriguez Prieto, M.A., Otero Rivas, M.M., Sanchez Sambucety, P., Garcia-Ruiz de Morales, J.M.   +4 more
core   +1 more source

Photoinduced acute exanthematous pustulosis caused by dicloxacillin and exposure to sunlight

Clinical Case Reports, 2020
Photoinduced acute exanthematous pustulosis is a rare condition; only few cases of photo‐AEP have been described previously with drugs such as norfloxacin, ciprofloxacin, and enoxacin. In this case, the reaction is seen after intake of dicloxacillin.
Rikke M. Nielsen, Kristine A. Pallesen
doaj   +1 more source

Case Report: Successful Treatment of Acute Generalized Exanthematous Pustulosis With Secukinumab

Frontiers in Medicine, 2021
Acute generalized exanthematous pustulosis is a severe, usually drug-related reaction, characterized by an acute onset of mainly small non-follicular pustules on an erythematous base.
Liangliang Zhang, Qiuyun Xu, Tingting Lin, Shifan Ruan, Mengting Lin, Chengbei Bao, Jing Zhang, Tao Liu, Ting Gong, Chao Ji   +9 more
doaj   +1 more source

Acute generalized exanthematous pustulosis induced by duloxetine

JEADV Clinical Practice, 2023
Duloxetine is a serotonin and norepinephrine reuptake inhibitor. Some rare duloxetine‐induced hypersensitivity skin reactions have been reported. We report a case of acute generalized exanthematous pustulosis potentially induced by duloxetine.
Numa Deydier, Hélène Jantzem, Zarrin Alavi, Glen Le Flahec, Marine Robert, Anne‐Marie Roguedas‐Contios, Emilie Brenaut, Laurent Misery, Greta Gourier   +8 more
doaj   +1 more source

Acute Generalized Exanthematous Pustulosis in a 76-year-Old Man With Neuroendocrine Carcinoma of the Lung, Responsive to Ixekizumab. [PDF]

Clin Cosmet Investig Dermatol
Jing Zhang,* Yue Chen,* Duanni Xu, Shaoyin Ma, Yichuan Gan, Yuwu Luo Guangzhou Dermatology Hospital, Guangzhou, Guangdong, People’s Republic of China*These authors contributed equally to this workCorrespondence: Yue Chen; Yuwu Luo, Guangzhou ...
Zhang J, Chen Y, Xu D, Ma S, Gan Y, Luo Y.   +5 more
europepmc   +2 more sources

Acute generalized exanthematous pustulosis [PDF]

Journal of Clinical and Scientific Research, 2012
Acute generalized exanthematous pustulosis (AGEP) is a rare reaction pattern with a typical morphology and a short clinical course that in majority of cases is related to medication administration.
K.S. Dhillon, K. Saxena, K.Garg, M.S. Umar   +3 more
doaj  

A Case Report of Possibly Related Acute Generalized Exanthematous Pustulosis with Staphylococcus pettenkoferi

Clinical, Cosmetic and Investigational Dermatology, 2023
Su Wang, Juan Bai, Jianjun Qiao Department of Dermatology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, People’s Republic of ChinaCorrespondence: Jianjun Qiao; Juan Bai, Email qiaojianjun@zju.edu.cn; 1515033 ...
Wang S, Bai J, Qiao J
doaj  

Steroid-resistant Acute Generalized Exanthematous Pustulosis Mimicking Generalized Pustular Psoriasis Successfully Treated by Methotrexate

Revista da Sociedade Portuguesa de Dermatologia e Venereologia, 2021
Acute generalized exanthematous pustulosis is a rare drug-induced eruption that is characterized by sterile non-follicular pustules arising on an often edematous diffuse erythematous background.
Khairuddin Djawad
doaj   +1 more source

Safety outcomes of antidiabetic medications: A comprehensive review of the EU summaries of product characteristics and international clinical practice guidelines

British Journal of Clinical Pharmacology, EarlyView.
Aims Information on the safety profile of antidiabetic medications is essential for informed treatment decisions in type 2 diabetes mellitus. Although this information is available in regulatory documents of individual drugs, a comprehensive overview across all approved antidiabetics is lacking.
David Liang, Daniala L. Weir, Safana Thevasahayam, Vera H. M. Deneer, Arno Siebes, Helga Gardarsdottir   +5 more
wiley   +1 more source

Updated EAACI Statement on Drug Hypersensitivity Skin Testing: Methodology and Non‐Irritative Concentrations

Allergy, EarlyView.
ABSTRACT These updated EAACI guidelines aim to standardize skin testing methodologies for both immediate and non‐immediate drug hypersensitivity reactions. For immediate reactions, the optimal testing window is 4–6 weeks post‐reaction; whereas beyond 6 months, false‐negative results increase.
Annick Barbaud, Lene Heise Garvey, Elizabeth Phillips, Michael Ardern‐Jones, Sevim Bavbek, Patrizia Bonadonna, Jean‐Christoph Caubet, Ana‐Maria Copaescu, Valentina Gueli, Jose Julio Laguna, Ricardo Madrigal‐Burgaleta, Francesca Mori, Vito Sabato, Maria J Torres, Knut Brockow   +14 more
wiley   +1 more source